Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?

Zisong Wei,Hua Chai,Yan Chen,Yue Cheng,Xiaojing Liu
DOI: https://doi.org/10.1016/j.coph.2021.08.006
IF: 4.768
2021-10-01
Current Opinion in Pharmacology
Abstract:Nicotinamide adenine dinucleotide (NAD) is essential for cellular physiological processes, directly or indirectly affecting metabolism and gene expression. The decline of NAD+ levels in the heart is accompanied by aging, causing cardiac pathological remodeling and dysfunction. Niacinamide mononucleotide (NMN) has emerged as a precursor to alleviate age-related cardiac pathophysiological changes by improving cardiac NAD+ homeostasis. Preclinical trials on the efficacy and safety of intaking NMN have shown encouraging results, revealing a cardioprotective effect without significant side effects. Strategies for improving the effectiveness of NMN are also evolving. The present review aimed to summarize the potentials of NMN as a nutraceutical against cardiac aging and highlight the relationship between NMN supplementation and cardiac protection.
pharmacology & pharmacy
What problem does this paper attempt to address?